Navigation Links
First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships
Date:6/30/2009

ool, friends, and the medical community because these symptoms are not confined to pain during sex, or even to the sexually active, and can be experienced by girls and women of all ages. Further, "Secret Suffering" addresses the effect of sexual pain on same sex relationships and contains a chapter about men who are afflicted.

Experts in the field agree this work is needed. According to Jill Osborne, President of the Interstitial Cystitis (IC) Network (IC is a common form of pelvic pain triggered by the bladder), "Until now, very few patients talked about their experience … Susan has been a driving force in creating this book and, partnered with Dr. Echenberg, now offers hope and encouragement to millions of women struggling with this condition … I can't say enough about this book. It's at the very top of books I will be recommending to patients struggling with IC and intimacy."

Lisa Martinez, Executive Director of The Women's Sexual Health Foundation said, "Susan Bilheimer and Robert J. Echenberg, MD, FACOG, have brought to our attention the challenges and severe frustrations of those with chronic pelvic pain. Secret Suffering will help women and men overcome many of those challenges and not feel so alone in their efforts to overcome such debilitating pain."

An Amazon reviewer and patient had this to say, "'Secret Suffering' has been a bridge for my family and friends to understand better what I have been going through. It's hard enough for me to understand, but thanks to this book, I can now relate with other patients and learn more about my body and how it works. It's a must read for the patient, partner, or friend. Don't miss it."

"With the divorce rate skyrocketing, and millions of women suffering in silence, it's time to bring the 'secret' out of hiding, and provide hope, help, and support to couples who suffer," Bilheimer says.

Dr. Echenberg agrees. &
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... high cost of drug advertising that does little to...iversity of British Columbia health policy researc...ves of Internal Medicine , examined the US sales p...own by the trade name Plavix used to prevent blood...selected to study the impact of advertising on sal...
(Date:11/23/2009)... from women,s hair loss for almost ten years, Zsan...ng her progress and the secret behind her success ...of her video diaries which include a direct compar... , (PRWeb UK) November 23,...klosi has released the video diaries that document...
(Date:11/23/2009)...se the problem, researchers say , , MOND...their anger over unfair treatment at work could be...es. , Men who consistently failed to express th... or supervisor were more than twice as likely to h...e who vented their anger, claims a report in the N...
(Date:11/23/2009)...stCall/--InfoLogix,Inc.(Nasdaq: IFLG ),aleadingtec...healthcareandcommercialindustries,announcedtodayth...mensHealthServices,hasjoinedInfoLogixasVicePreside...://www.newscom.com/cgi-bin/prnh/20090618/NE35135LO...vicesforInfoLogix,Mr.Waywillberesponsiblefortheful...
(Date:11/23/2009)...wswire/--TheAmericanSocietyofHematology(ASH)andSch...dmediacompany,arelaunching"ExploretheMysteryofBloo...tinthefieldsofscienceandmedicine,inadditiontoexpos...gy. ,, "Manyhematologistsmayrememberwatchingaca...elearningaboutbloodreallyfun,"statedNancyBerliner,...
Breaking Medicine News(10 mins):Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...4 CryoCor, Inc. (Nasdaq:,CRYO), a medical device ...hmias, announced today the publication of a Europe...ith CryoCor,s Cardiac Cryoablation System.,The pur...cused on isolating the pulmonary veins to treat th...
...utes of counseling helped people cut down on exces... -- Even a little counseling on the dangers of alc...n help problem drinkers cut back by at least three...t to almost 7,800 emergency patients in 14 univers...
...Jan. 2 Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that it has received final approval fr...ration (FDA) on its Abbreviated,New Drug Applicati...Sulfate product is the,generic equivalent to Dey, ...
...Jan. 2 Barr Pharmaceuticals,Inc. (NYSE: BRL ) to...es,Inc. has received final approval from the U.S. ... version of Roche Laboratories Inc.,s KYTRIL(R),(g...8, 2007, and plans to launch its product shortly.,...
... Mo. An estimated 750,000 hospitalized patients ..., and less than 30 percent of those leave the hosp...3 issue of the New England Journal of Medicine, re...c arrest known as ventricular arrhythmia. They fou...
...ncludes special deal and free unique support chann...YSE: MED ) today announced that the Company is of...closed Pure Weight Loss centers. Medifast is,offer...fast is also offering former Pure Weight Loss clie...
Other Medicine News:Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 2Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 3Health News:Brief Chat With ER Docs Can Curb Problem Drinking 2Health News:Watson Receives FDA Approval for Generic DuoNeb(R) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 3Health News:For hospital patients, defibrillation delays mean lower survival 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 3
(Date:11/23/2009)...INTRICHMOND,Calif.,Nov.23/PRNewswire-FirstCall/--T...nouncedthatitisscheduledtomeetwiththeU.S.FoodandDr...ompleteResponseLetterregardingtheNewDrugApplicatio...ingualtablet).Aspreviouslyannounced,theCompleteRes...dicatedthattheFDAcouldnotapprovetheNDAinitspresent...
(Date:11/23/2009)...MBRIDGE,Mass.,Nov.23/PRNewswire/--LigonDiscovery,I...hnologytofinddrugsagainsthigh-valuetargets,todayan...anErrolB.DeSouzaasLigon,sExecutiveChairmanoftheBoa...ecutiveChairmanoftheBoard,"saidPatrickKleyn,Ligon,...,sbreadthofexperienceinthelifesciencesindustry--pa...
(Date:11/23/2009)...llowingtheFDAapprovalsoftwonewtherapiesforNon-Hodg...nupdatedtoincludeofatumumab(Azerra(TM),GlaxoSmithK...yticleukemia(CLL)andromidepsin(Istodax(R),Gloucest...withcutaneousT-celllymphoma(CTCL). ,, FORTWASHI...FDAapprovalshavepromptedtheNationalComprehensiveCa...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 1CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 2CEL SCI Corporation to Raise 2420 Million in Registered Direct Offering 57405 3Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 1Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 2PharmAbcine Closes USD 246 Million Series A Financing 14102 1PharmAbcine Closes USD 246 Million Series A Financing 14102 2PharmAbcine Closes USD 246 Million Series A Financing 14102 3PharmAbcine Closes USD 246 Million Series A Financing 14102 4
...ME TSX: COM, VANCOUVER and DEERFIELD, IL, June 04,...p. and its,co-development partner Astellas Pharma ... their recently completed Phase 3 clinical,study, ... safety of,the intravenous formulation of vernakal...atment of patients who developed,atrial fibrillati...
...ent Ever to Demonstrate Significant Survival Benef...wswire-FirstCall/ -- Bayer,HealthCare Pharmaceutic...unced that Nexavar(R) (sorafenib) tablets signific...epatocellular carcinoma,(HCC), or primary liver ca...p-value=0.0006). Results were presented at the 43r...
Other Medicine Technology:Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: